| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Immunovant, Inc. | Chief Operating Officer | Common Stock | 110K | $3.25M | $29.53 | Nov 18, 2024 | Direct |
| ACELYRIN, Inc. | Chief Operating Officer | Common Stock | 130K | $582K | $4.47 | May 15, 2024 | Direct |
| ACELYRIN, Inc. | Chief Operating Officer | Employee Stock Option (right to buy) | 184K | May 23, 2024 | Direct | ||
| Immunovant, Inc. | Chief Operating Officer | Stock Option (right to buy) | 137K | Nov 18, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | Nov 18, 2024 | 2 | $0 | 4 | Nov 20, 2024 | Chief Operating Officer |
| IMVT | Immunovant, Inc. | Nov 18, 2024 | 0 | $0 | 3 | Nov 20, 2024 | Chief Operating Officer |
| SLRN | ACELYRIN, Inc. | May 23, 2024 | 1 | $0 | 4 | May 24, 2024 | Chief Operating Officer |
| SLRN | ACELYRIN, Inc. | May 15, 2024 | 1 | -$46K | 4 | May 17, 2024 | Chief Operating Officer |
| SLRN | ACELYRIN, Inc. | Jan 9, 2024 | 1 | $0 | 4 | Jan 11, 2024 | Chief Operating Officer |
| SLRN | ACELYRIN, Inc. | Aug 16, 2023 | 1 | $0 | 4 | Aug 18, 2023 | Chief Operating Officer |
| SLRN | ACELYRIN, Inc. | May 9, 2023 | 6 | $0 | 4 | May 11, 2023 | Chief Operating Officer |
| SLRN | ACELYRIN, Inc. | May 4, 2023 | 1 | $0 | 4 | May 4, 2023 | Chief Operating Officer |
| SLRN | ACELYRIN, Inc. | May 4, 2023 | 0 | $0 | 3 | May 4, 2023 | Chief Operating Officer |